Whistleblower Claims Lead to Big Settlements for Pathology Group and Laboratory

By Kelly A. Briganti, Editorial Director, G2 Intelligence Two separate False Claims Act cases initiated by whistleblowers have resulted in settlements for a North Carolina pathology group and a … [Read more...]

Philanthropy Giants Funding Medical Research

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Facebook founder Mark Zuckerberg grabbed headlines this week because of the letter he and his wife wrote to their newborn daughter … [Read more...]

Transgenomic Sells Genetic Test Business To Japanese Company

By Ron Shinkman, Editor, Laboratory Industry Report Struggling Transgenomic has exited the genetic assay business. The Omaha, Neb.-based company announced this week it had sold its genetic assays and … [Read more...]

AABB and A2LA Form Laboratory Accreditation Partnership

By Kelly A. Briganti, Editorial Director, G2 Intelligence Providing laboratories with a three-for-one assessment opportunity to streamline their accreditation processes, the AABB and the American … [Read more...]

Cigna Becomes First Insurer to Cover Whole Exome Sequencing

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Cigna became the first national health insurance plan to publish a coverage policy on whole exome sequencing (WES). The insurer … [Read more...]

HHS’ Top Ten Management Problems Include Labs

By Kelly A. Briganti, Editorial Director, G2 Intelligence The OIG's FY 2015 Top Management and Performance Challenges target clinical laboratories among other providers as a necessary focus of efforts … [Read more...]

Avellino Expands Gene Testing for LASIK Prep Test

By Ron Shinkman, Editor, Laboratory Industry Report California-based Avellino Labs has expanded its molecular testing menu for patients who are considering lasik or other elective surgeries that will … [Read more...]

OIG Semiannual Report to Congress Highlights Fraud Recoveries

By Kelly A. Briganti, Editorial Director, G2 Intelligence The OIG released its Semiannual Report to Congress detailing its program integrity and oversight activities for the second half of the 2015 … [Read more...]

FDA and CMS Address LDT Regulation Before Energy and Commerce Committee

By Kelly A. Briganti, Editorial Director, G2 Intelligence Last week, the U.S. House of Representatives Energy and Commerce Committee heard testimony about oversight of laboratory developed tests … [Read more...]

USPSTF Recommendations Cut PSA Testing; More Personalized Screening Called For

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Prostate-specific antigen (PSA) screening rates, along with the incidence of early-stage prostate cancer, have declined since the … [Read more...]


(-00000g2)